Various inflammatory diseases are associated with the excessive formation of leukotrienes (LTs) and prostaglandins (PGs). Herein, we present a novel class of dual inhibitors of 5- lipoxygenase (5-LO) and microsomal prostaglandin E2 synthase-1 (mPGES-1), key